Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
54.60
-0.20 (-0.37%)
Dec 2, 2025, 4:25 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 41.84M NOK in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 172.52M, up 17.42% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.

Revenue (ttm)
172.52M
Revenue Growth
+17.42%
P/S Ratio
4.88
Revenue / Employee
2.74M
Employees
63
Market Cap
842.06M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024152.07M16.92M12.52%
Dec 31, 2023135.15M23.23M20.76%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Medistim ASA662.18M
Nordhealth AS590.33M
Navamedic ASA539.42M
Photocure ASA537.59M
Omda AS476.29M
Vistin Pharma ASA455.25M
ContextVision AB115.15M
ArcticZymes Technologies ASA109.99M
Revenue Rankings